165 related articles for article (PubMed ID: 28792799)
1. Investigating Associations Between Proliferation Indices, C-kit, and Lymph Node Stage in Canine Mast Cell Tumors.
Krick EL; Kiupel M; Durham AC; Thaiwong T; Brown DC; Sorenmo KU
J Am Anim Hosp Assoc; 2017; 53(5):258-264. PubMed ID: 28792799
[TBL] [Abstract][Full Text] [Related]
2. Cellular proliferation in canine cutaneous mast cell tumors: associations with c-KIT and its role in prognostication.
Webster JD; Yuzbasiyan-Gurkan V; Miller RA; Kaneene JB; Kiupel M
Vet Pathol; 2007 May; 44(3):298-308. PubMed ID: 17491070
[TBL] [Abstract][Full Text] [Related]
3. c-KIT messenger RNA and protein expression and mutations in canine cutaneous mast cell tumors: correlations with post-surgical prognosis.
Giantin M; Vascellari M; Morello EM; Capello K; Vercelli A; Granato A; Lopparelli RM; Nassuato C; Carminato A; Martano M; Mutinelli F; Dacasto M
J Vet Diagn Invest; 2012 Jan; 24(1):116-26. PubMed ID: 22362941
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of prognostic markers for canine mast cell tumors treated with vinblastine and prednisone.
Webster JD; Yuzbasiyan-Gurkan V; Thamm DH; Hamilton E; Kiupel M
BMC Vet Res; 2008 Aug; 4():32. PubMed ID: 18700956
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis and Prognosis of Canine Cutaneous Mast Cell Tumors.
Kiupel M; Camus M
Vet Clin North Am Small Anim Pract; 2019 Sep; 49(5):819-836. PubMed ID: 31178200
[TBL] [Abstract][Full Text] [Related]
6. Expression of Phosphorylated KIT in Canine Mast Cell Tumor.
Halsey CHC; Thamm DH; Weishaar KM; Burton JH; Charles JB; Gustafson DL; Avery AC; Ehrhart EJ
Vet Pathol; 2017 May; 54(3):387-394. PubMed ID: 28129097
[TBL] [Abstract][Full Text] [Related]
7. Canine subcutaneous mast cell tumors: cellular proliferation and KIT expression as prognostic indices.
Thompson JJ; Yager JA; Best SJ; Pearl DL; Coomber BL; Torres RN; Kiupel M; Foster RA
Vet Pathol; 2011 Jan; 48(1):169-81. PubMed ID: 21160022
[TBL] [Abstract][Full Text] [Related]
8. Expression of Ki67, BCL-2, and COX-2 in canine cutaneous mast cell tumors: association with grading and prognosis.
Vascellari M; Giantin M; Capello K; Carminato A; Morello EM; Vercelli A; Granato A; Buracco P; Dacasto M; Mutinelli F
Vet Pathol; 2013 Jan; 50(1):110-21. PubMed ID: 22673539
[TBL] [Abstract][Full Text] [Related]
9. Prevalence and prognostic value of c-kit and TP53 mutations in canine mast cell tumours.
Vozdova M; Kubickova S; Fictum P; Fröhlich J; Jelinek F; Rubes J
Vet J; 2019 May; 247():71-74. PubMed ID: 30971355
[TBL] [Abstract][Full Text] [Related]
10. Canine mast cell tumors: correlation of apoptosis and proliferation markers with prognosis.
Scase TJ; Edwards D; Miller J; Henley W; Smith K; Blunden A; Murphy S
J Vet Intern Med; 2006; 20(1):151-8. PubMed ID: 16496935
[TBL] [Abstract][Full Text] [Related]
11. In situ c-KIT mRNA quantification of canine cutaneous mast cell tumours and its relationship to prognostic factors.
Seung BJ; Cho SH; Kim SH; Bae MK; Lim HY; Sur JH
Vet Comp Oncol; 2021 Mar; 19(1):132-139. PubMed ID: 32926564
[TBL] [Abstract][Full Text] [Related]
12. Validation of the prognostic value of histopathological grading or c-kit mutation in canine cutaneous mast cell tumours: a retrospective cohort study.
Takeuchi Y; Fujino Y; Watanabe M; Takahashi M; Nakagawa T; Takeuchi A; Bonkobara M; Kobayashi T; Ohno K; Uchida K; Asano K; Nishimura R; Nakayama H; Sugano S; Ohashi Y; Tsujimoto H
Vet J; 2013 Jun; 196(3):492-8. PubMed ID: 23384436
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of exon 11 internal tandem duplications in the C-KIT proto-oncogene in Australian canine mast cell tumours.
Tamlin VS; Kessell AE; Mccoy RJ; Dobson EC; Smith TS; Hebart M; Brown L; Mitrovic D; Peaston AE
Aust Vet J; 2017 Oct; 95(10):386-391. PubMed ID: 28948627
[TBL] [Abstract][Full Text] [Related]
14. Comparison of serum tryptase as a diagnostic oncological marker in canine versus human mast cell neoplasms.
De Vos S; Demeyere K; De Cock H; Devriendt N; Schwarzkopf I; Fortrie R; Roggeman T; Meyer E; De Spiegelaere W; de Rooster H
Res Vet Sci; 2022 Dec; 151():90-95. PubMed ID: 35872552
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the kinase domain of c-KIT in canine cutaneous mast cell tumors.
Webster JD; Kiupel M; Yuzbasiyan-Gurkan V
BMC Cancer; 2006 Apr; 6():85. PubMed ID: 16579858
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of Kit receptor tyrosine kinase dysregulations in feline cutaneous mast cell tumors.
Sabattini S; Guadagni Frizzon M; Gentilini F; Turba ME; Capitani O; Bettini G
Vet Pathol; 2013 Sep; 50(5):797-805. PubMed ID: 23377219
[TBL] [Abstract][Full Text] [Related]
17. Mutations in Exons 8 and 11 of
Chen P; Marconato L; Sabattini S; Kiupel M
Vet Sci; 2022 Sep; 9(9):. PubMed ID: 36136708
[TBL] [Abstract][Full Text] [Related]
18. Comparison of minichromosome maintenance protein 7, Ki67 and mitotic index in the prognosis of intermediate Patnaik grade cutaneous mast cell tumours in dogs.
Berlato D; Murphy S; Laberke S; Rasotto R
Vet Comp Oncol; 2018 Dec; 16(4):535-543. PubMed ID: 29989314
[TBL] [Abstract][Full Text] [Related]
19. Ki67/KIT double immunohistochemical staining in cutaneous mast cell tumors from Boxer dogs.
Fonseca-Alves CE; Bento DD; Torres-Neto R; Werner J; Kitchell B; Laufer-Amorim R
Res Vet Sci; 2015 Oct; 102():122-6. PubMed ID: 26412531
[TBL] [Abstract][Full Text] [Related]
20. Assessment of Canine Mast Cell Tumor Mortality Risk Based on Clinical, Histologic, Immunohistochemical, and Molecular Features.
Horta RS; Lavalle GE; Monteiro LN; Souza MCC; Cassali GD; Araújo RB
Vet Pathol; 2018 Mar; 55(2):212-223. PubMed ID: 29338615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
